Gault Cheryl 4
4 · Rapport Therapeutics, Inc. · Filed Jul 1, 2026
Research Summary
AI-generated summary of this filing
Rapport Therapeutics (RAPP) COO Cheryl Gault Sells 9,000 Shares
What Happened
- Cheryl Gault, Chief Operating Officer of Rapport Therapeutics (RAPP), sold a total of 9,000 common shares in open-market transactions on June 30, 2026, generating aggregate proceeds of approximately $415,799. The sales were executed in four groups: 1,900 shares at a $40.09 weighted avg ($76,174), 3,792 shares at $41.39 weighted avg ($156,964), 3,308 shares at $42.17 weighted avg ($139,506), and 1,000 shares at $43.15 weighted avg ($43,155). These are sales (not purchases), which are often routine dispositions rather than an explicit bullish signal.
Key Details
- Transaction date: 2026-06-30 (filed 2026-07-01; appears timely under Form 4 reporting rules).
- Lot-level weighted average prices and ranges:
- 1,900 shares — $40.09 WAP (trades ranged $39.61–$40.58) — $76,174 (F2)
- 3,792 shares — $41.39 WAP (trades ranged $40.80–$41.79) — $156,964 (F3)
- 3,308 shares — $42.17 WAP (trades ranged $41.81–$42.75) — $139,506 (F4)
- 1,000 shares — $43.15 WAP (trades ranged $42.81–$43.65) — $43,155 (F5)
- Total shares sold: 9,000; total proceeds: ~$415,799.
- Plan/authority: Transactions effected pursuant to a Rule 10b5-1 trading plan adopted December 10, 2025 (F1), indicating pre-scheduled sales.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Filing timeliness: Report filed 2026-07-01 for trades on 2026-06-30 (appears timely; no late-report flag noted).
Context
- Sales executed under a 10b5-1 plan are pre-arranged and generally intended to avoid trading on material non-public information; they are common for insiders managing diversification or liquidity needs. For retail investors, purchases typically carry more direct informational weight than routine insider sales.
Insider Transaction Report
Form 4
Gault Cheryl
Chief Operating Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-06-30$40.09/sh−1,900$76,174→ 158,014 total - Sale
Common Stock
[F1][F3]2026-06-30$41.39/sh−3,792$156,964→ 154,222 total - Sale
Common Stock
[F1][F4]2026-06-30$42.17/sh−3,308$139,506→ 150,914 total - Sale
Common Stock
[F1][F5]2026-06-30$43.15/sh−1,000$43,155→ 149,914 total
Footnotes (5)
- [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.61 to $40.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.80 to $41.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.81 to $43.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Signature
/s/ Troy Ignelzi, Attorney-in-Fact|2026-07-01